Optibrium Acquires BioPharmics LLC
August 31, 2023
Optibrium, a Cambridge-based developer of software and AI solutions for small-molecule drug discovery, has acquired BioPharmics LLC to expand its 3D ligand- and structure-based drug design and visualisation capabilities. The acquisition brings BioPharmics' algorithms and products (including ForceGen, Surflex-Dock, eSim and QuanSA) and its founding scientists into Optibrium's StarDrop platform to strengthen 3D modelling, docking and binding-affinity prediction functionality.
- Buyers
- Optibrium
- Targets
- BioPharmics LLC
- Industry
- Software
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Ott Scientific Acquires American Bionostica
April 1, 2021
Medical Devices
Ott Scientific has acquired American Bionostica, Inc., a developer and manufacturer of specialty lateral flow assays; the acquisition was effective April 1 and ABI will operate inside Ott Scientific’s Ethos Biosciences subsidiary. The American Bionostica team will join Ott Scientific, with expanded research and production capacity planned at Ott Scientific’s new ISO13485/cGMP space in Logan Township, New Jersey.
-
Bruker Corporation Acquires biocrates life sciences ag
June 3, 2025
Biotechnology
Bruker Corporation has acquired biocrates life sciences ag, an Innsbruck, Austria-based leader in mass-spectrometry-based quantitative metabolomics. The deal adds biocrates' metabolomics kits, assays, software and contract research services to Bruker's multiomics strategy, expanding Bruker's MS-based metabolomics and integrated multiomics capabilities. Financial terms were not disclosed.
-
VeriSIM Life Acquires Molomics Biotech
May 11, 2022
Biotechnology
VeriSIM Life, an AI-driven virtual drug development company based in San Francisco, has acquired Molomics Biotech SL, a Barcelona-based AI-enabled drug discovery firm. The acquisition integrates Molomics' AI + Human Collective Intelligence discovery technology into VeriSIM's BIOiSIM platform to accelerate and improve success rates in drug discovery, including work on Parkinson's disease.
-
QuartzBio (Precision for Medicine) Acquires SolveBio
January 24, 2023
Cloud & SaaS
QuartzBio, a business unit of Precision for Medicine, has acquired SolveBio and integrated its enterprise biomarker and genomic data management platform into QuartzBio’s end-to-end SaaS suite. The acquisition expands QuartzBio’s capabilities for sample inventory, biomarker data management and enterprise-level visibility to better serve pharmaceutical and biotech clients in clinical research and development.
-
Curia Acquires LakePharma to Expand Biologics R&D and Manufacturing Capabilities
February 14, 2022
Biotechnology
Curia (formerly AMRI) has acquired LakePharma Inc., a US-based biologics contract research, development and manufacturing organization with operations in California, Massachusetts and Texas. The deal adds LakePharma's six facilities and ~235 employees to Curia's global network, creating expanded end-to-end capabilities from discovery through GMP manufacturing for biologics.
-
Astrix Acquires Blue Ocean Informatics
August 20, 2025
Healthcare Services
Astrix has closed its acquisition of Blue Ocean Informatics, adding specialized lab informatics and LabWare expertise to its life science consulting offerings. The deal expands Astrix's laboratory informatics bench and service capabilities for pharmaceutical, research, and life sciences clients; integration begins immediately with no expected service disruptions.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.